Array BioPharma, Inc. Appoints Dr. Neil Spector to Its Scientific Advisory Board

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today announced the appointment of Neil Spector, M.D., to its Scientific Advisory Board. Dr. Spector will focus on helping Array in the development of its cancer portfolio.

MORE ON THIS TOPIC